Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Antipsychotic Sample Kits Recalled
10/12/2018
Mislabeled physician sample kits containing prescription antipsychotic medications used in the treatment of people with schizophrenia, bipolar disorder, depression, Tourette syndrome, and autism are being recalled.
Mislabeled physician sample kits containing prescription antipsychotic medications used in the treatment of people with schizophrenia, bipolar disorder, depression, Tourette syndrome, and autism are being recalled.
Mislabeled physician sample kits...
10/12/2018
Pharmacy Learning Network
News
Class I Recall for Muscle Relaxant
10/12/2018
A prescription medication indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions is being recalled.
A prescription medication indicated for the relief of discomfort associated with acute, painful musculoskeletal conditions is being recalled.
A prescription medication...
10/12/2018
Pharmacy Learning Network
News
Trevena`s Opioid Painkiller Fails to Get FDA Panel Backing
10/11/2018
An opioid injection for managing acute pain failed to win the backing of an advisory panel to the FDA. 
An opioid injection for managing acute pain failed to win the backing of an advisory panel to the FDA. 
An opioid injection for managing...
10/11/2018
Pharmacy Learning Network

Advertisement

News
Pfizer Settles New York Probe Into `Deceptive` Copay Coupons
10/11/2018
Pfizer settled charges that it misled consumers in its drug copayment coupon program into thinking they would pay far less to fill prescriptions than they ended up having to shell out.
Pfizer settled charges that it misled consumers in its drug copayment coupon program into thinking they would pay far less to fill prescriptions than they ended up having to shell out.
Pfizer settled charges that it...
10/11/2018
Pharmacy Learning Network
News
Shortened IV Antibiotic Course Works for Uncomplicated Group B Strep
10/11/2018
Researchers examined the impact of a shorter course of IV antibiotics for uncomplicated, late-onset group B Streptococcus. 
Researchers examined the impact of a shorter course of IV antibiotics for uncomplicated, late-onset group B Streptococcus. 
Researchers examined the impact...
10/11/2018
Pharmacy Learning Network
News
U.S. FDA Panel Backs Celltrion Copycat of Roche Blood Cancer Drug
10/11/2018
A biosimilar copy of a blockbuster cancer drug recently won unanimous backing from an advisory panel to the FDA.
A biosimilar copy of a blockbuster cancer drug recently won unanimous backing from an advisory panel to the FDA.
A biosimilar copy of a...
10/11/2018
Pharmacy Learning Network

Advertisement

News
Gout Drug Lowers CKD Risk
10/10/2018
Researchers examined the impact a gout treatment had on chronic kidney disease risk. 
Researchers examined the impact a gout treatment had on chronic kidney disease risk. 
Researchers examined the impact...
10/10/2018
Pharmacy Learning Network
News
Appetite-Suppressant Reduces Diabetes Risk
10/10/2018
A selective serotonin 2C receptor agonist and appetite-suppressant drug is associated with a decreased risk of diabetes, according to recent findings.
A selective serotonin 2C receptor agonist and appetite-suppressant drug is associated with a decreased risk of diabetes, according to recent findings.
A selective serotonin 2C...
10/10/2018
Pharmacy Learning Network
News
"Compelling" Evidence of Link Between Aspirin Use, Lower Hepatoma Risk
10/10/2018
Regular, long-term use of aspirin is associated with a reduced risk of developing hepatocellular carcinoma, according to recent data. 
Regular, long-term use of aspirin is associated with a reduced risk of developing hepatocellular carcinoma, according to recent data. 
Regular, long-term use of...
10/10/2018
Pharmacy Learning Network

Advertisement

News
FDA Staff Says AcelRx Opioid Painkiller is not Better Than Rivals
10/10/2018
According the staff reviewers of the FDA, an opioid painkiller offers no apparent advantage to currently available therapies. 
According the staff reviewers of the FDA, an opioid painkiller offers no apparent advantage to currently available therapies. 
According the staff reviewers of...
10/10/2018
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023

Featuring David Rubin, MD

Featuring David Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023

Featuring Paul Schulz, MD 

Featuring Paul Schulz, MD 
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023

Featuring Ronald Vender, MD, FRCPC

Featuring Ronald Vender, MD, FRCPC ...
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023

Featuring Abigail Cline, MD, PhD, FAAD

Featuring Abigail Cline, MD, PhD, FAA...
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023

Featuring Paul Schulz, MD

Featuring Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023

Featuring Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC

Featuring Chris Fausel, PharmD, MHA, ...
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use